Hope Shipman
Endocrinology, Diabetes & Metabolism · Houston, TXNPI 1932170719
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in TX, where the typical reported total is $2,974.
Across 103 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valeritas, Inc.$285
- Sanofi-aventis U.S. LLC$212
- AstraZeneca$156
- Abbott$134
- Novo Nordisk$134
- Insulet Corporation$85
- plus $697 from 18 others
What the payments were for
- Food & beverage$1,698100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valeritas, Inc. | 21 | $285 |
| Sanofi-aventis U.S. LLC | 9 | $212 |
| AstraZeneca | 9 | $156 |
| Abbott | 8 | $134 |
| Novo Nordisk | 12 | $134 |
| Insulet Corporation | 5 | $85 |
| Lilly USA, LLC | 5 | $85 |
| Corcept Therapeutics | 4 | $70 |
| Medtronic | 4 | $64 |
| Amgen | 3 | $50 |
| IBSA Pharma Inc. | 3 | $50 |
| Mannkind Corporation | 2 | $49 |
| Shire North American Group Inc | 2 | $48 |
| AbbVie | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $40 |
| Merck | 3 | $39 |
| Radius Health, Inc. | 2 | $35 |
| Dexcom, Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Companion Medical, Inc. | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$124
How this compares
$1,704 in reported general payments places this provider in the 40th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.
See all endocrinology, diabetes & metabolism providers in Texas →
Other endocrinology, diabetes & metabolism in Houston
- Rocio HarbisonHouston$989K
- Andres SplenserHouston$923K
- Daniel TungHouston$753K
- Damaris VegaHouston$565K
- Steven PetakHouston$452K
- Amin JamalHouston$217K
- Laila TabatabaiHouston$207K
- Rakesh PatelHouston$187K
- Veena WatweHouston$157K
- Tiana ShiverHouston$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.